Tag: Eisai
Leqembi fully approved in the US for the first time
Frankfurt The US Food and Drug Administration (FDA) has granted full approval for the first time for a therapy that slows the progression of Alzheimer’s disease. This was announced by…
Strong gains on Wall Street – Curevac shares gain more than 23 percent
new York A solid US jobs report amid easing wage pressures has allayed interest rate worries on Wall Street. The Dow Jones index of standard values closed 2.1 percent higher…
FDA grants preliminary approval for new Alzheimer’s drug
Frankfurt On Friday evening, the American drug agency FDA granted preliminary approval for the new Alzheimer’s drug lecanemab, thereby raising hopes for further progress in the fight against dementia. The…
Investors on Wall Street are stepping on the brakes
New York Stock Exchange Investors held back on Wall Street. (Photo: AP) new York Investors on Wall Street started the week down after the recent rally. The Dow Jones index…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Alzheimer’s drug gantenerumab disappointed in clinical studies
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The pharmaceutical company Roche and its German partner Morphosys have to accept a new setback in…
Roche’s Alzheimer’s drug disappoints in clinical trials
Roche building The Swiss have suffered another setback in Alzheimer’s research. (Photo: RERUTERS) Zurich The Swiss pharmaceutical giant Roche has to cope with another research setback with a new Alzheimer’s…
New data from drug research expected in autumn
Alzheimer’s disease Protein deposits in the brain – so-called amyloid plaques – are one of the main characteristics of Alzheimer’s disease. Many of the drug candidates currently being researched aim…
So it is with the new Alzheimer’s therapy
Neurologist Alois Alzheimer, drug Aduhelm To date, there is no drug that can cure the disease. (Photo: Mauritius Images, Getty Images, REUTERS (M)) Frankfurt “Will there be a breakthrough in…